CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 49 enrolled
Drug / intervention
Amphetaminedrug
Likely dose
Amphetamine 0.4mg/kgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02348385
NCT02348385N/ACompleted
CompareCT.gov

Imaging Extrastriatal Dopamine Release in Tobacco Smokers and Nonsmokers

Yale University·observational·Posted Jan 28, 2015·Updated Mar 2, 2023

In Brief

An observational study evaluating Amphetamine for Nicotine Dependence. Completed, enrolled 49 participants across 1 site.

Detailed Summary

The goal is to examine sex differences in amphetamine-induced dopamine release in tobacco smokers and nonsmokers.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsNicotine Dependence
CountriesUnited States
CollaboratorsNational Institute on Drug Abuse (NIDA)

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedJan 28, 2015
Enrollment StartDec 1, 2012
Primary CompletionDec 1, 2017
TodayJul 2, 2026
Enrollment to primary: 5 yearsPosted 11.4 years ago

Interventions

Amphetaminedrug

Subjects will have 2 PET scans on the same day. Up to 3 hours before the second PET Scan, amphetamine (0.4mg/kg, orally) will be administered.